Pharmatech Co.: Detailed Company Information & Corporate Profile

Contact top employees from Pharmatech Co.

Summary

The company currently specializes in the Pharmaceuticals area. The annual revenue of Pharmatech Co. varies between 1 and 10M. To connect with Pharmatech Co. employee register on SignalHire.

Pharmatech Co. Websitepharmatechlb.de
Industries
Pharmatech Co. Headquarters addressMRF Quattro, Gulan Street, Erbil, 44001 IQ
Company Size100-200 employees
SpecialtiesProduct development, Medicine, Pharmaceutical products, Food supplements
Founded2010
Estimated Annual Revenue$1 - 10M

Workforce Turnover

Length of Employment

arrow

Pharmatech Co.'s workforce includes employees across a wide range of tenure levels.

20% have been with the company for 1 to 2 years60% have been with the company for 5 to 7 years20% have been with the company for more than 11 years
Contact top employees from Pharmatech Co.
Ahmed Jamal
Ahmed JamalDeputy CEO
Unlock contacts
Abdullah Farhan
Abdullah FarhanHead of scientific department
Unlock contacts
akar yousif
akar yousifArea Supervisor
Unlock contacts
Pshwar Ali
Pshwar AliTeam Leader
Unlock contacts
Mohammed Abdulkareem
Mohammed AbdulkareemAdministrative Assistant
Unlock contacts

Pharmatech Co. Corporate Information: FAQ

Pharmatech Co. operates in the Pharma industries. More details can be found on the official website: pharmatechlb.de.
Pharmatech Co. has offices located in Erbil, IQ.
The headquarters of Pharmatech Co. are located in Erbil, Iraq.
Pharmatech Co. currently employs 100-200 people.
Pharmatech Co.'s revenue is approximately 4.2M.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP